EmailFacebookXLinkedIn

Lina_S

About Lina Silva Salinas

This author has not yet filled in any details.
So far Lina Silva Salinas has created 407 blog entries.

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08–02 study

2023-05-31T11:49:13+02:00

Sébastien Gendarme Sonia Zebachi Romain Corre Laurent Greillier Grégoire Justeau Olivier Bylicki Chantal Decroisette Jean-Bernard Auliac Florian Guisier Margaux Geier Charles Ricordel Maxime Frelaut Elena Paillaud Christos Chouaïd Florence Canouï-Poitrine Published: May 19, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101506

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08–02 study2023-05-31T11:49:13+02:00

Medication assessment in older adults with cancer – Current practices in clinical pharmacy

2023-05-31T11:47:23+02:00

Darren J. Walsh Kavita Kantilal Chloé Herledan Ginah Nightingale Vanya Slavova-Boneva Maria-Estela Moreno-Martínez Samantha Penn Joey Chien Kumud Kantilal Published: May 19, 2023 DOI :https://doi.org/10.1016/j.jgo.2023.101531

Medication assessment in older adults with cancer – Current practices in clinical pharmacy2023-05-31T11:47:23+02:00

Evolving oncology care for older adults: Trends in telemedicine use after one year of caring for older adults with cancer during COVID-19

2023-05-31T11:38:59+02:00

Mariuxi A. Viteri Malone Leana Cabrera Chien Mackenzi Pergolotti Beverly Canin Nicolò Matteo Luca Battisti Jessica L. Krok-Schoen Anahat Kaur Karlynn BrintzenhofeSzoc Elana Plotkin Leigh M. Boehmer Armin Shahrokni Published: May 15, 2023 DOI:https://doi.org/10.1016/j.jgo.2023.101497

Evolving oncology care for older adults: Trends in telemedicine use after one year of caring for older adults with cancer during COVID-192023-05-31T11:38:59+02:00

Interview with the Author – The Climb Study: Endocrine Therapy in Older Women with Breast Cancer

2023-06-01T13:18:42+02:00

The CLIMB Study Breast cancer remains a significant health concern for older women, who account for appoximately 50% of those diagnosed with the condition. Older patients often have reduced physiological reserve and clinically significant comorbidities, and are more susceptible to both undertreatment and to overtreatment, as well as being more likely to experience treatment toxicity and early discontinuation of therapy. Around 70-80% of breast cancers are categorized as estrogen-receptor (ER) positive. Regardless of the disease stage or setting, a majority of patients diagnosed with ER+ cancers are likely, at some point during their treatment course, to be treated with endocrine therapy (ET), which works to block or prevent estrogen signaling, and is typically taken for between five to ten years in the adjuvant setting. In general, ET comes in one of two forms, either aromatase inhibitors (AI), such as exemestane and letrozole, or selective estrogen receptor modulators (SERMs) such as [...]

Interview with the Author – The Climb Study: Endocrine Therapy in Older Women with Breast Cancer2023-06-01T13:18:42+02:00

Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients

2023-04-26T10:18:07+02:00

Agata Rembielak, Thomas Yau, Baran Akagunduz, Sandrine Aspeslagh, Giuseppe Colloca, Aoife Conway, Falalu Danwata, Veronique del Marmol, Chuck O'Shea, Marthe Verhaert, Rado Zic, Dan Livesey. Published: April 19, 2023 DOI: https://doi.org/10.1016/j.jgo.2023.101502

Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients2023-04-26T10:18:07+02:00

University of Rochester Medical Center

2023-04-11T14:57:25+02:00

Geriatrics PD: Thomas CaprioMed Onc PD: Mohamed TejaniGeriOnc Supporter: Supriya MohileProgram OpportunitiesResearch: at least 1 year, self-funded is preferableClinical: 2-3 years of hematology/oncology fellowship and/or 1 year of geriatricsFunding available: Clinical funding through hematology/oncology and geriatrics fellowshipDuration of program: 3-4 years for clinical fellowship, at least 1 year for researchApplication process: Through ERAS for clinical fellowship, email for research opportunitiesAccepts international trainees: Please inquire with program directorContact person: Fellowship program coordinator – Dina Henchen, Dina_Henchen@URMC.Rochester.eduWebsite

University of Rochester Medical Center2023-04-11T14:57:25+02:00

Concerns and difficulties associated with the COVID-19 pandemic among older adults with cancer in Mexico

2023-04-11T14:54:58+02:00

Sofia Sánchez-Román, Yanin Chavarri-Guerra, Ingrid Vargas-Huicochea, Asunción Alvarez-Del-Río, Pilar Bernal Pérez, Daniela Ramirez Maza, Andrea De La O. Murillo, Andrea Morales Alfaro, Enrique Soto-Perez-de-Celis. Published: March 28, 2023 DOI: https://doi.org/10.1016/j.jgo.2023.101486

Concerns and difficulties associated with the COVID-19 pandemic among older adults with cancer in Mexico2023-04-11T14:54:58+02:00

Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial

2023-03-28T09:29:39+02:00

Heidi D. Klepin, Janet A. Tooze, Rhonda L. Bitting, Brittany Davis, Katherine Pleasant, Ana Clara Melo, Katherine Cook, David R. Soto-Pantoja, E. Ann Tallant, Patricia E. Gallagher. Published: March 27, 202 3DOI: https://doi.org/10.1016/j.jgo.2023.101478

Study design and methods for the pilot study of muscadine grape extract supplement to improve fatigue among older adult cancer survivors (FOCUS) trial2023-03-28T09:29:39+02:00

Stay in touch and share our news!

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +41 22 734 73 43
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Stay in the loop with SIOG’s newsletter!

Subscribe now

Powered by K.I.T. Group – Crafted for Excellence

Go to Top